Optimization of formulation parameters for the preparation of flutamide liposomes by 33 factorial 26-term logit model

Pharmaceutical Development and Technology

Volumn 9, Issue 4, 2004, Pages 369-377

  Murthy, R S R ^a   Umrethia, Manish L ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Factorial design; Flutamide; Liposomes

Indexed keywords

CHLOROFORM; CHOLESTEROL; CHOLINE DERIVATIVE; DRUG CARRIER; FLUTAMIDE; LIPOSOME; METHANOL; PHOSPHOTIDYLCHOLINE; UNCLASSIFIED DRUG; WATER;

ARTICLE; CANCER THERAPY; DRUG ABSORPTION; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TARGETING; EXPERIMENTAL MODEL; FACTORIAL ANALYSIS; PARTICLE SIZE; PHYSICAL PHASE; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS;

CHEMISTRY, PHARMACEUTICAL; DATA INTERPRETATION, STATISTICAL; FLUTAMIDE; LIPOSOMES; METHODS; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOTOMICROGRAPHY;

EID: 8744242017     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-200032999     Document Type: Article

References (14)

1. Baker, J.W.; Bachman, G.L.; Schumacher, I.; Raman, D.P.; Thorp, A. Synthesis and bacteriostatic activity of nirtrofluromethylenilides. J. Med. Chem. 1967, 10, 93-95.
2. Asade, R.H.; Prizont, L.; Muino, J.P.; Tessler, J. Steady state hydroxyflutamide plasma levels after the administration of two dosage forms of flutamide. Cancer Chemother. Pharmacol. 1991, 27, 401-405.
3. Gomez, J.Z.; Dupont, A.; Cusan, L.; Tremblay, M.; Suburo, R.; Lemay, M.; Labrie, F. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am. J. Med. 1992, 92, 465-470.
4. Betagiri, G.V.; Jenkins, S.A.; Parsons, D.L. Preparation of liposomes. In Liposomal Drug Delivery Systems, 10th Ed.; Technomic Publications: Lancaster, 1993; 1-26.
5. Knight, C.G. From physical structure to therapeutic application. In Liposomes; Elsevier/North-Holand Biomedical Press: New York, 1981.
6. Bangham, A.D.; Standish, M.M.; Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965, 13, 238-252.
7. Armstrong, N.A.; James, K.C. Understanding Experimental Designs and Interpretation in Pharmaceutics; Ellis Horwood Publicatons: London, UK, 1990; 27-54.
8. 3 factorial design and the desirability function. Int. J. Pharm. 2002, 248 (1), 51-60.
9. Juslin, L.; Antikainen, O.; Merkku, P.; Yliruusi, J. Droplet size measurement: I. Effect of three independent variables on droplet size distribution and spray angle from a pneumatic nozzle. Int. J. Pharm. 1995, 123, 247-256.
10. Betagiri, G.V.; Jenkins, S.A.; Parsons, D.L. Stability of liposomes. In Liposomal Drug Delivery Systems, 10th Ed.; Technomic Publications: Lancaster, 1993; 27-56.
11. Schulz, M.; Schmoldt, A.; Donn, F.; Becker, H. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur. J. Clin. Pharmacol. 1988, 34, 633-636.
12. Bhalerao, S.S.; Harshal, A.R. Preparation, optimization, characterization and stability studies of salicylic acid liposomes. Drug Dev. Ind. Pharm. 2003, 29 (4), 451-467.
13. Stewart, J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980, 104, 10-14.
14. Zlatkis, A.; Zak, B.; Boyle, A.J. A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med. 1953, 41, 486-492.